Clinical Trial Update: Safety and Efficacy of S-8184 in Treatment of Locally Advanced, Metastatic, or Recurrent TCC of the Urothelium [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating S-8184 for locally advanced, metastatic, or recurrent urothelial carcinoma (transitional cell carcinoma of the urothelium); safety and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• S-8184

Snippet

Sponsor: Achieve Life Sciences | Conditions: Urologic Neoplasms | Phase 2 | Status: COMPLETED